Patent details
92336 Product Name: "Trastuzumab emtansine et ses dérivés pharmaceutiquement acceptables (KADCYLA)"
Basic Information
- Publication number:
- 92336
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP047938964
- Legal Status:
- Active
- Application number:
- 92336
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/13/885 - KADCYLA -trastuzumab emtansine
- Marketing Authorization Type:
- Marketing Authorization Date:
- 19/11/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 16/12/2013
- First Marketing Authorization date:
- 19/11/2013
- Grant date:
- 17/02/2014
- Activation date:
- 12/10/2024
- Publication date:
- 17/02/2014
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 19/11/2028
- SPC Extension Expiration:
- 19/11/2028
- Rejection date:
- Withdrawal date:
Owner
- From:
- 16/12/2013
- Name:
- ImmunoGen Inc.
- Address:
- 830 Winter Street, Waltham, MA 02451, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 16/12/2013
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- XIE Hongsheng
- Address:
- United States (US)
2
- Name:
- STEEVES Rita
- Address:
- United States (US)
3
- Name:
- KOVTUN Yelena
- Address:
- United States (US)
4
- Name:
- LUTZ Robert
- Address:
- United States (US)
5
- Name:
- CHARI Ravi
- Address:
- United States (US)
Publication
Bulletin
1
- Bulletin Heading:
- SPC4
- Bulletin edition number:
- 2019/02
- Publication date:
- 22/02/2019
- Description:
- Section F : Correction of granted supplementary protection certificates – I9 publication
2
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 02/11/2026
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 430 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 15/09/2025
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 16/01/2019 | Outgoing Correspondence | 1 |
| 16/01/2019 | Publication | 1 |
| 02/04/2014 | Incoming Correspondence (Post) | 3 |